A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study
Open accessThe DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: To determine the most cost-effective method of screening for atrial fibrillation (AF) in the population aged 65 years and over, as well as its prevalence and incidence in this age group. Also to evaluate the relative cost-effectiveness of different methods of recording and interpreting the electrocardiogram (ECG) within a screening programme. DESIGN: Multicentred randomised controlled trial. Purposefully selected general practices were randomly allocated to 25 intervention practices and 25 control practices. SETTING: Fifty primary care centres across the West Midlands, UK. PARTICIPANTS: Patients aged 65 years and over. INTERVENTIONS: GPs and practice nurses in the intervention practices received education on the importance of AF detection and ECG interpretation. Patients in the intervention practices were randomly allocated to systematic (n = 5000) or opportunistic screening (n = 5000). Prospective identification of pre-existing risk factors for AF within the screened population enabled comparison between targeted screening of people at higher risk of AF and total population screening. MAIN OUTCOME MEASURES: AF detection rates in systematically screened and opportunistically screened populations in the intervention practices were compared with AF detection rate in 5000 patients in the control practices. The screening period was 12 months. RESULTS: Baseline prevalence of AF was 7.2%, with a higher prevalence in males (7.8%) and patients aged 75 years and over (10.3%). The control population demonstrated higher baseline prevalence (7.9%) than either the systematic (6.9%) or opportunistic (6.9%) intervention population. In the control population 47 new cases were detected (incidence 1.04% per year). In the opportunistic arm 243 patients without a baseline diagnosis of AF were found to have an irregular pulse, with 177 having an ECG, yielding 31 new cases (incidence 0.69% per year). A further 44 cases were detected outside the screening programme (overall incidence 1.64% per year). In the systematic arm 2357 patients had an ECG yielding 52 new cases (incidence 1.1% per year). Of these, 31 were detected by targeted screening and a further 21 by total population screening. A further 22 cases were detected outside the screening programme (overall incidence 1.62% per year). In terms of ECG interpretation, computerised decision support software (CDSS) gave a sensitivity of 87.3%, a specificity of 99.1% and a positive predictive value (PPV) of 89.5% compared with the gold standard (cardiologist reporting). GPs and practice nurses performed less well. The only difference in performance between intervention populations and controls was that practice nurses from the control arm performed less well than with intervention practice nurses on interpretation of limb-lead (PPV 38.8% versus 20.8%) and single-lead (PPV 37.7% versus 24.0%) ECGs. The within-trial economic evaluation results showed the lowest incremental cost to be for the opportunistic arm, with an incremental cost-effectiveness ratio of 337 pounds Sterling for each additional case detected compared to the control arm. Opportunistic screening dominated both more intensive screening strategies. Model-based analyses showed small differences in cost and quality-adjusted life-years for different methods and intensities of screening, but annual opportunistic screening resulted in the lowest number of ischaemic strokes and greatest proportion of cases of AF diagnosed. Probabilistic sensitivity results indicated that there was a probability of approximately 60% that screening from the age of 65 years was cost-effective in both men and women. CONCLUSIONS: The results of the study indicated that in terms of a screening programme for atrial fibrillation in patients 65 and over, the only strategy that improved on routine practice was opportunistic screening, model-based analyses indicated that there was a probability of approximately 60% of annual opportunistic screening being cost effective. It is suggested that the following topics are worthy of further investigation: the effect of the implementation of a screening programme for AF on the uptake and maintenance of anticoagulation in patients aged 65 years and over; an evaluation of the role of CDSS in the diagnosis of cardiac arrythmias; the best method for routinely detecting paroxysmal AF; ways of improving healthcare professionals' performance in ECG interpretation; development of a robust economic model to incorporate data on new therapeutic agents for use as thromboprophylactic agents for patients with AF, and an evaluation of the relative risk of stroke for patients with incident as opposed to prevalent AF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“reports of other screening instruments have suggested minimal burden and disruption of the clinical workflow.”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [460]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“A data monitoring committee will often comprise members from a variety of disciplines.363 451 452”
From SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials (2025) · cites this paper as [363]
Experimental — accuracy not yet measuredIn the citing paper
“Blinding of data monitoring committee members is generally discouraged.363”
From SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials (2025) · cites this paper as [363]
In the citing paper
“Independence, particularly from the sponsor and trial investigators, is a key characteristic of the data monitoring committee and can be broadly defined as the committee comprising members who are “completely uninvolved in the running of the trial and who cannot be unfairly influenced (either directly or indirectly) by people, or institutions, involved in the trial.”363 452”
From SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials (2025) · cites this paper as [363]
In the citing paper
“Opportunistic screening for silent AF seems cost-effective in elderly populations (e.g.> 65 years), 131 and similar effects have been reported using single-lead ECG screening in other at-risk populations.132,133”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [131]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., & Singer, D. E. (2001) · JAMA · doi:10.1001/jama.285.18.2370 · Cited by 6,205
Marteau, T. M., & Bekker, H. (1992) · British Journal of Clinical Psychology · doi:10.1111/j.2044-8260.1992.tb00997.x · Cited by 3,238
Principles and Practice of Screening for Disease.
(1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-69-5-1085_2 · Cited by 3,066
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
Feinberg, W. M. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.5.469 · Cited by 2,274
(1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420130036007 · Cited by 2,071
Petersen, P., Godtfredsen, J., Boysen, G., Andersen, E., & Andersen, B. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91200-2 · Cited by 1,820
EAFT (European Atrial Fibrillation Trial) Study Group (1993) · The Lancet · doi:10.1016/0140-6736(93)92358-z · Cited by 1,741
Principles and Practice of Screening for Disease.
Zavon, M. R. (1969) · Archives of Internal Medicine · doi:10.1001/archinte.1969.00300130131020 · Cited by 1,356
Research works printed but not linked: 16
- [10]10. Lake RR, Cullen KJ, deKlerk NH, McCall MG, Rosman DL. Atrial fibrillation in an elderly population. Aust N Z J Med 1989;19:321-6.
- [11]11. Philips SJ, Whisnant J, O'Fallon WM, Frye RL. Prevalence of cardiovascular disease and diabetes in residents of Rochester, Minnesota. Mayo Clin Proc 1990;65:344-59.
- [15]15. Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 1991;18:349-55.
- [19]19. Laupacis A, Albers G, Connolly S. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Arch Intern Med 1994;154:1449-57.
- [23]23. Albers GW. Atrial fibrillation and stroke. Arch Intern Med 1994;154:1443-8.
- [24]24. Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low- intensity, fixed-dose warfarin plus aspirin for high- risk patients with atrial fibrillation: Stroke References Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 1996;348:633-8.
- [34]34. Atrial Fibrillation Investigators. The efficacy of aspirin in patients with atrial fibrillation: analysis of pooled data from 3 randomised trials. Arch Intern Med 1997;157:1237-40.
- [35]35. Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation. Ann Intern Med 1992;116:6-12.
- [38]38. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost effectiveness analysis in medicine and health. Oxford: Oxford University Press; 1996.
- [41]41. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiological features of chronic atrial fibrillation: the Framingham Study. N Engl J Med 1982;306:1018-22.
- [44]44. Hobbs FDR. Should all patients with atrial fibrillation be assessed by a cardiologist? Plenary session. Proceedings from Consensus Conference on the Management of Atrial Fibrillation. Edinburgh: RCP Edinburgh; 1998.
- [57]57. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer MD. Prevalence of diagnosed atrial fibrillation in adults. JAMA 2001;285:2370-5.
- [60]60. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-6. J Neurol Neurosurg Psychiatry 1990;53:16-22.
- [63]63. Office for National Statistics. Health Statistics Quarterly, 22. London: Office for National Statistics; 2004.
- [67]67. Robinson A, Thomson R, Parkin D, Sudlow M, Eccles M. How patients with atrial fibrillation value different health outcomes. Journal of Health Services and Research Policy 2001;6:92-8. References
- [73]73. Gray JAM. Dimensions and definitions of screening. Milton Keynes: NHS Executive Anglia; Oxford: Research and Development Directorate; 1996.
Cited by
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P. E., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 9,971
Self-citation2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · Europace · doi:10.1093/europace/euw295 · Cited by 6,439
Self-citation2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
Self-citationDeveloped with the special contribution of the European Heart Rhythm Association (EHRA), Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), Authors/Task Force Members, Camm, A. J., Kirchhof, P., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Van Gelder, I. C., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,864
Self-citation2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Lip, G. Y. H., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P., ESC Committee for Practice Guidelines (CPG), et al. (2012) · EP Europace · doi:10.1093/europace/eus305 · Cited by 3,822
Self-citationVan Gelder, I. C., Rienstra, M., Bunting, K. V., Casado-Arroyo, R., Caso, V., Crijns, H. J. G. M., De Potter, T. J. R., Dwight, J., Guasti, L., Hanke, T., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae176 · Cited by 3,024
“101 The burden of AF required to initiate OAC therapy is not known.”
BackgroundSelf-citation2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Lip, G. Y. H., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P., ESC Committee for Practice Guidelines (CPG), et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs253 · Cited by 2,899
Self-citationMeschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650
Guidelines for the management of atrial fibrillation
Developed with the special contribution of the European Heart Rhythm Association (EHRA), Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), Authors/Task Force Members, Camm, A. J., Kirchhof, P., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Van Gelder, I. C., et al. (2010) · EP Europace · doi:10.1093/europace/euq350 · Cited by 1,747
Self-citationMant, J., Hobbs, F. R., Fletcher, K., Roalfe, A., Fitzmaurice, D., Lip, G. Y., & Murray, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61233-1 · Cited by 1,556
Self-citationKrijthe, B. P., Kunst, A., Benjamin, E. J., Lip, G. Y. H., Franco, O. H., Hofman, A., Witteman, J. C. M., Stricker, B. H., & Heeringa, J. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht280 · Cited by 1,419
Self-citation2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403
Self-citationGoldstein, L. B., Bushnell, C. D., Adams, R. J., Appel, L. J., Braun, L. T., Chaturvedi, S., Creager, M. A., Culebras, A., Eckel, R. H., Hart, R. G., et al. (2011) · Stroke · doi:10.1161/str.0b013e3181fcb238 · Cited by 1,306
Pathophysiological mechanisms of atrial fibrillation: a translational appraisal
Schotten, U., Verheule, S., Kirchhof, P., & Goette, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00031.2009 · Cited by 1,273
Goldstein, L. B., Bushnell, C., Adams, R. J., Appel, L. J., Braun, L. T., Chaturvedi, S., Creager, M. A., Culebras, A., Eckel, R. H., Hart, R. G., et al. (2011) · Stroke · Cited by 745
Halcox, J. P. J., Wareham, K., Cardew, A., Gilmore, M., Barry, J. P., Phillips, C., & Gravenor, M. B. (2017) · Circulation · doi:10.1161/circulationaha.117.030583 · Cited by 580
Andrade, J. G., Aguilar, M., Atzema, C., Bell, A., Cairns, J. A., Cheung, C. C., Cox, J. L., Dorian, P., Gladstone, D. J., Healey, J. S., et al. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.09.001 · Cited by 562
Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration
Freedman, B., Camm, J., Calkins, H., Healey, J. S., Rosenqvist, M., Wang, J., Albert, C. M., Anderson, C. S., Antoniou, S., Benjamin, E. J., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.026693 · Cited by 537
Self-citationLowres, N., Neubeck, L., Salkeld, G., Krass, I., McLachlan, A. J., Redfern, J., Bennett, A. A., Briffa, T., Bauman, A., Martinez, C., et al. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-03-0231 · Cited by 458
Watanabe, H., Tanabe, N., Watanabe, T., Darbar, D., Roden, D. M., Sasaki, S., & Aizawa, Y. (2008) · Circulation · doi:10.1161/circulationaha.107.744466 · Cited by 427
International Consensus Statement on Obstructive Sleep Apnea
Chang, J. L., Goldberg, A. N., Alt, J. A., Mohammed, A., Ashbrook, L., Auckley, D., Ayappa, I., Bakhtiar, H., Barrera, J. E., Bartley, B. L., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23079 · Cited by 350
Lip, G. Y., Tse, H. F., & Lane, D. A. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61514-6 · Cited by 338
Self-citationLau, J. K., Lowres, N., Neubeck, L., Brieger, D. B., Sy, R. W., Galloway, C. D., Albert, D. E., & Freedman, S. B. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.01.220 · Cited by 326
Screening to identify unknown atrial fibrillation: A systematic review
Lowres, N., Neubeck, L., Redfern, J., & Freedman, S. B. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-02-0165 · Cited by 327
Brieger, D., Amerena, J., Attia, J., Bajorek, B., Chan, K. H., Connell, C., Freedman, B., Ferguson, C., Hall, T., Haqqani, H., et al. (2018) · Heart, Lung and Circulation · doi:10.1016/j.hlc.2018.06.1043 · Cited by 327
Raghunath, S., Pfeifer, J. M., Ulloa-Cerna, A. E., Nemani, A., Carbonati, T., Jing, L., vanMaanen, D. P., Hartzel, D. N., Ruhl, J. A., Lagerman, B. F., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.047829 · Cited by 312
Prevalence, Incidence, and Lifetime Risk of Atrial Fibrillation in China
Guo, Y., Tian, Y., Wang, H., Si, Q., Wang, Y., & Lip, G. Y. H. (2015) · Chest · doi:10.1378/chest.14-0321 · Cited by 255
Self-citationMairesse, G. H., Moran, P., Van Gelder, I. C., Elsner, C., Rosenqvist, M., Mant, J., Banerjee, A., Gorenek, B., Brachmann, J., Varma, N., et al. (2017) · EP Europace · doi:10.1093/europace/eux177 · Cited by 250
Self-citationThe WATCH AF trial: SmartWATCHes for detection of atrial fibrillation
Dörr, M., Nohturfft, V., Brasier, N., Bosshard, E., Djurdjevic, A., Gross, S., Raichle, C. J., Rhinisperger, M., Stöckli, R., & Eckstein, J. (2019) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2018.10.006 · Cited by 245
The Epidemiology of Atrial Fibrillation and Stroke
Pistoia, F., Sacco, S., Tiseo, C., Degan, D., Ornello, R., & Carolei, A. (2016) · Cardiology Clinics · doi:10.1016/j.ccl.2015.12.002 · Cited by 244
Lip, G. Y. H., Fauchier, L., Freedman, S. B., Van Gelder, I., Natale, A., Gianni, C., Nattel, S., Potpara, T., Rienstra, M., Tse, H.-F., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.16 · Cited by 238
Self-citationKrittanawong, C., Rogers, A. J., Johnson, K. W., Wang, Z., Turakhia, M. P., Halperin, J. L., & Narayan, S. M. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00445-9 · Cited by 234
Management of atrial fibrillation
Lip, G. Y., & Tse, H.-F. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61300-2 · Cited by 229
Self-citationPrevalencia de fibrilación auricular en España. Resultados del estudio OFRECE
Gómez-Doblas, J. J., Muñiz, J., Martin, J. J. A., Rodríguez-Roca, G., Lobos, J. M., Awamleh, P., Permanyer-Miralda, G., Chorro, F. J., Anguita, M., & Roig, E. (2014) · Revista Española de Cardiología · doi:10.1016/j.recesp.2013.07.015 · Cited by 222
Hughes, M., Lip, G. Y. H., & on behalf of the Guideline Development Group for the NICE national clinical guideline for management of atrial fibrillation in primary and secondary care (2007) · QJM · doi:10.1093/qjmed/hcm076 · Cited by 217
Self-citationWireless smartphone ECG enables large-scale screening in diverse populations
HABERMAN, Z. C., JAHN, R. T., BOSE, R., TUN, H., SHINBANE, J. S., DOSHI, R. N., CHANG, P. M., & SAXON, L. A. (2015) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12634 · Cited by 212
Pink, J., Lane, S., Pirmohamed, M., & Hughes, D. A. (2011) · BMJ · doi:10.1136/bmj.d6333 · Cited by 216
CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials
Hopewell, S., Chan, A.-W., Collins, G. S., Hróbjartsson, A., Moher, D., Schulz, K. F., Tunn, R., Aggarwal, R., Berkwits, M., Berlin, J. A., et al. (2025) · BMJ · doi:10.1136/bmj-2024-081124 · Cited by 205
Di Carlo, A., Bellino, L., Consoli, D., Mori, F., Zaninelli, A., Baldereschi, M., Cattarinussi, A., D’Alfonso, M. G., Gradia, C., Sgherzi, B., et al. (2019) · EP Europace · doi:10.1093/europace/euz141 · Cited by 187
Prevalence of Atrial Fibrillation in Spain. OFRECE Study Results
Gómez-Doblas, J. J., Muñiz, J., Martin, J. J. A., Rodríguez-Roca, G., Lobos, J. M., Awamleh, P., Permanyer-Miralda, G., Chorro, F. J., Anguita, M., & Roig, E. (2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.07.014 · Cited by 187
Davis, R. C., Hobbs, F. D. R., Kenkre, J. E., Roalfe, A. K., Iles, R., Lip, G. Y. H., & Davies, M. K. (2012) · Europace · doi:10.1093/europace/eus087 · Cited by 180
Self-citationScreening for atrial fibrillation: a call for evidence
Jones, N. R., Taylor, C. J., Hobbs, F. D. R., Bowman, L., & Casadei, B. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz834 · Cited by 178
A deep learning approach to monitoring and detecting atrial fibrillation using wearable technology
Shashikumar, S. P., Shah, A. J., Li, Q., Clifford, G. D., & Nemati, S. (2017) · 2017 IEEE EMBS International Conference on Biomedical & Health Informatics (BHI) · doi:10.1109/bhi.2017.7897225 · Cited by 164
Mant, J., Fitzmaurice, D. A., Hobbs, F. D. R., Jowett, S., Murray, E. T., Holder, R., Davies, M., & Lip, G. Y. H. (2007) · BMJ · doi:10.1136/bmj.39227.551713.ae · Cited by 166
Self-citationUS Preventive Services Task Force, Curry, S. J., Krist, A. H., Owens, D. K., Barry, M. J., Caughey, A. B., Davidson, K. W., Doubeni, C. A., Epling, J. W., Kemper, A. R., et al. (2018) · JAMA · doi:10.1001/jama.2018.10321 · Cited by 165
Screening for Atrial Fibrillation: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Davidson, K. W., Barry, M. J., Mangione, C. M., Cabana, M., Caughey, A. B., Davis, E. M., Donahue, K. E., Doubeni, C. A., Epling, J. W., et al. (2022) · JAMA · doi:10.1001/jama.2021.23732 · Cited by 163
Aronsson, M., Svennberg, E., Rosenqvist, M., Engdahl, J., Al-Khalili, F., Friberg, L., Frykman-Kull, V., & Levin, L.-Å. (2015) · Europace · doi:10.1093/europace/euv083 · Cited by 154
SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials
Hróbjartsson, A., Boutron, I., Hopewell, S., Moher, D., Schulz, K. F., Collins, G. S., Tunn, R., Aggarwal, R., Berkwits, M., Berlin, J. A., et al. (2025) · BMJ · doi:10.1136/bmj-2024-081660 · Cited by 171
2018 Korean Guideline of Atrial Fibrillation Management
Joung, B., Lee, J., Lee, K. H., Kim, T., Choi, E., Lim, W., Kang, K., Uhm, J., Lim, H. E., Park, J., et al. (2018) · Korean Circulation Journal · doi:10.4070/kcj.2018.0339 · Cited by 164
Accurate detection of atrial fibrillation from 12-lead ECG using deep neural network
Cai, W., Chen, Y., Guo, J. Q., Han, B., Shi, Y., Ji, L., Wang, J., Zhang, G., & Luo, J. (2019) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2019.103378 · Cited by 171
Kirchhof, P., Breithardt, G., Bax, J., Benninger, G., Blomstrom-Lundqvist, C., Boriani, G., Brandes, A., Brown, H., Brueckmann, M., Calkins, H., et al. (2016) · Europace · doi:10.1093/europace/euv304 · Cited by 141
“Screening for unknown AF and initiation of anticoagulation has the potential to prevent strokes in patients with undiagnosed AF, but has so far mainly been evaluated in physician offices, where pulse palpation followed by 12-lead electrocardiogram (ECG) recording seems cost-effective for AF screening.(23,54) A recent…”
BackgroundSelf-citationScreening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis
Welton, N. J., McAleenan, A., Thom, H. H., Davies, P., Hollingworth, W., Higgins, J. P., Okoli, G., Sterne, J. A., Feder, G., Eaton, D., et al. (2017) · Health Technology Assessment · doi:10.3310/hta21290 · Cited by 141
Lip, G. Y. H., Clémenty, N., Pericart, L., Banerjee, A., & Fauchier, L. (2014) · Stroke · doi:10.1161/strokeaha.114.007199 · Cited by 161
“Permanent 335 (7) 78 (5) 45 (3) 15 (2) 3 (1)”
InfluentialSelf-citationReview of epidemiology and management of atrial fibrillation in developing countries
Nguyen, T. N., Hilmer, S. N., & Cumming, R. G. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.01.184 · Cited by 139
Predicting atrial fibrillation in primary care using machine learning
Hill, N. R., Ayoubkhani, D., McEwan, P., Sugrue, D. M., Farooqui, U., Lister, S., Lumley, M., Bakhai, A., Cohen, A. T., O’Neill, M., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0224582 · Cited by 137
Watanabe, H., Tanabe, N., Yagihara, N., Watanabe, T., Aizawa, Y., & Kodama, M. (2011) · Circulation Journal · doi:10.1253/circj.cj-11-0780 · Cited by 149
Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction
Potpara, T., Ferro, C. J., & Lip, G. Y. H. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2018.19 · Cited by 140
Self-citationAdverse prognosis of incidentally detected ambulatory atrial fibrillation: A cohort study
Martinez, C., Katholing, A., & Freedman, S. B. (2014) · Thrombosis and Haemostasis · doi:10.1160/th4-04-0383 · Cited by 127
Lowres, N., Olivier, J., Chao, T.-F., Chen, S.-A., Chen, Y., Diederichsen, A., Fitzmaurice, D. A., Gomez-Doblas, J. J., Harbison, J., Healey, J. S., et al. (2019) · PLOS Medicine · doi:10.1371/journal.pmed.1002903 · Cited by 124
Self-citationDiagnostic assessment of a deep learning system for detecting atrial fibrillation in pulse waveforms
Poh, M.-Z., Poh, Y. C., Chan, P.-H., Wong, C.-K., Pun, L., Leung, W. W.-C., Wong, Y.-F., Wong, M. M.-Y., Chu, D. W.-S., & Siu, C.-W. (2018) · Heart · doi:10.1136/heartjnl-2018-313147 · Cited by 120
Jonas, D. E., Kahwati, L. C., Yun, J. D. Y., Middleton, J. C., Coker-Schwimmer, M., & Asher, G. N. (2018) · JAMA · doi:10.1001/jama.2018.4190 · Cited by 119
“9) 116 (28) NR 14 (3) 109 (26) 218 (52) Warfarin, adjusted dose (n = 212) Control (n = 208)c 2.”
The effect of dapagliflozin on albuminuria in DECLARE-TIMI 58
Mosenzon, O., Wiviott, S. D., Heerspink, H. J. L., Dwyer, J. P., Cahn, A., Goodrich, E. L., Rozenberg, A., Schechter, M., Yanuv, I., Murphy, S. A., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0076 · Cited by 113
Yan, B. P., Lai, W. H. S., Chan, C. K. Y., Chan, S. C., Chan, L., Lam, K., Lau, H., Ng, C., Tai, L., Yip, K., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.008585 · Cited by 110
“Pulse palpation has a sensitivity of 92% but only a modest specificity of 82%, which means more false-positive results.(26) A recent systematic review and meta-analysis found that modified Table 1.”
BackgroundKearley, K., Selwood, M., Van den Bruel, A., Thompson, M., Mant, D., Hobbs, F. R., Fitzmaurice, D., & Heneghan, C. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004565 · Cited by 106
Self-citationWearables in cardiology: Here to stay
Dagher, L., Shi, H., Zhao, Y., & Marrouche, N. F. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.02.023 · Cited by 107
Taggar, J. S., Coleman, T., Lewis, S., Heneghan, C., & Jones, M. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487315611347 · Cited by 105
Lowres, N., Mulcahy, G., Jin, K., Gallagher, R. D., Neubeck, L., & Freedman, B. (2017) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivx348 · Cited by 124
Raftery, J. P., Hanney, S. R., Greenhalgh, T., Glover, M. J., & Blatch-Jones, A. (2016) · Health Technology Assessment · doi:10.3310/hta20760 · Cited by 128
Self-citationPopulation-Based Screening for Atrial Fibrillation
Khurshid, S., Healey, J. S., McIntyre, W. F., & Lubitz, S. A. (2020) · Circulation Research · doi:10.1161/circresaha.120.316341 · Cited by 101
Orchard, J., Lowres, N., Freedman, S. B., Ladak, L., Lee, W., Zwar, N., Peiris, D., Kamaladasa, Y., Li, J., & Neubeck, L. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316670255 · Cited by 100
Nielsen, J. C., Lin, Y., Figueiredo, M. J. D. O., Shamloo, A. S., Alfie, A., Bovéda, S., Dagres, N., Toro, D. D., Eckhardt, L. L., Ellenbogen, K. A., et al. (2020) · Journal of Arrhythmia · doi:10.1002/joa3.12338 · Cited by 108
Self-citationHypertension and atrial fibrillation: epidemiology, pathophysiology and therapeutic implications
Lau, Y.-F., Yiu, K., Siu, C.-W., & Tse, H.-F. (2011) · Journal of Human Hypertension · doi:10.1038/jhh.2011.105 · Cited by 105
Management of atrial fibrillation: Figure 1
Lip, G. Y. H., & Tello-Montoliu, A. (2006) · Heart · doi:10.1136/hrt.2005.071555 · Cited by 100
“With such a common and important condition, is it worth screening for AF? This was recently addressed in the SAFE (Screening for Atrial Fibrillation in the agEd) study,”
BackgroundSelf-citationNielsen, J. C., Lin, Y.-J., de Oliveira Figueiredo, M. J., Sepehri Shamloo, A., Alfie, A., Boveda, S., Dagres, N., Di Toro, D., Eckhardt, L. L., Ellenbogen, K., et al. (2020) · EP Europace · doi:10.1093/europace/euaa065 · Cited by 98
Self-citationQuality indicators for the care and outcomes of adults with atrial fibrillation
Arbelo, E., (Chair), Aktaa, S., Bollmann, A., D’Avila, A., Drossart, I., Dwight, J., Hills, M. T., Hindricks, G., Kusumoto, F. M., et al. (2021) · EP Europace · doi:10.1093/europace/euaa253 · Cited by 97
Self-citationJacobs, M. S., Kaasenbrood, F., Postma, M. J., van Hulst, M., & Tieleman, R. G. (2016) · Europace · doi:10.1093/europace/euw285 · Cited by 97
Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation
Grigioni, F., Benfari, G., Vanoverschelde, J.-L., Tribouilloy, C., Avierinos, J.-F., Bursi, F., Suri, R. M., Guerra, F., Pasquet, A., Rusinaru, D., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.067 · Cited by 93
Stroke in atrial fibrillation: epidemiology and thromboprophylaxis
Lip, G. Y. H. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04302.x · Cited by 105
Self-citationVerberk, W. J., Omboni, S., Kollias, A., & Stergiou, G. S. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.10.182 · Cited by 84
Kaleschke, G., Hoffmann, B., Drewitz, I., Steinbeck, G., Naebauer, M., Goette, A., Breithardt, G., & Kirchhof, P. (2009) · Europace · doi:10.1093/europace/eup262 · Cited by 81
“patients who would qualify for anticoagulant therapy if AF was present.(23) The device studied here could be used for simple, easy-to-use primary screening of outpatients at risk for AF.”
MethodStroke as the Initial Manifestation of Atrial Fibrillation: The Framingham Heart Study
Lubitz, S. A., Yin, X., McManus, D. D., Weng, L.-C. C., Aparicio, H. J., Walkey, A. J., Romero, J. R., Kase, C. S., Ellinor, P. T., Wolf, P. A., et al. (2017) · Stroke · doi:10.1161/strokeaha.116.015071 · Cited by 97
Ceornodolea, A. D., Bal, R. A., & Severens, J. L. (2017) · Stroke Research and Treatment · doi:10.1155/2017/8593207 · Cited by 104
Comparison of Atrial Fibrillation in the Young versus That in the Elderly: A Review
Sankaranarayanan, R., Kirkwood, G., Dibb, K., & Garratt, C. J. (2013) · Cardiology Research and Practice · doi:10.1155/2013/976976 · Cited by 78
Cost, Effectiveness, and Cost-Effectiveness
Diamond, G. A., & Kaul, S. (2009) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.108.793406 · Cited by 84
Hendrikx, T., Rosenqvist, M., Wester, P., Sandström, H., & Hörnsten, R. (2014) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-14-41 · Cited by 73
Prevalence of unknown atrial fibrillation in patients with risk factors
Samol, A., Masin, M., Gellner, R., Otte, B., Pavenstädt, H.-J., Ringelstein, E. B., Reinecke, H., Waltenberger, J. L., & Kirchhof, P. F. (2012) · EP Europace · doi:10.1093/europace/eus366 · Cited by 76
The molecular and functional identities of atrial cardiomyocytes in health and disease
Brandenburg, S., Arakel, E. C., Schwappach, B., & Lehnart, S. E. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.11.025 · Cited by 76
Stergiou, G. S., Kyriakoulis, K. G., Stambolliu, E., Destounis, A., Karpettas, N., Kalogeropoulos, P., & Kollias, A. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000002201 · Cited by 67
Willits, I., Keltie, K., Craig, J., & Sims, A. (2014) · Applied Health Economics and Health Policy · doi:10.1007/s40258-014-0096-7 · Cited by 67
Andrew, N. E., Thrift, A. G., & Cadilhac, D. A.-M. (2013) · Neuroepidemiology · doi:10.1159/000343667 · Cited by 82
Proietti, M., Mairesse, G. H., Goethals, P., Scavée, C., Vijgen, J. M., Blankoff, I., Vandekerckhove, Y. R., & Lip, G. Y. H. (2016) · EP Europace · doi:10.1093/europace/euw069 · Cited by 73
Self-citationHobbs, R. F., Taylor, C. J., Geersing, G. J., Rutten, F. H., Brouwer, J. R., & on behalf of the European Primary Care Cardiovascular Society (EPCCS) SPAF working group (2015) · European Journal of Preventive Cardiology · doi:10.1177/2047487315571890 · Cited by 74
Non-valvular atrial fibrillation and cognitive decline: a longitudinal cohort study
Park, H., Hildreth, A. J., Thomson, R., & O'Connell, J. (2007) · Age and Ageing · doi:10.1093/ageing/afl164 · Cited by 65
JCS/JHRS 2022 Guideline on Diagnosis and Risk Assessment of Arrhythmia
Takase, B., Ikeda, T., Shimizu, W., Abe, H., Aiba, T., Chinushi, M., Koba, S., KUSANO, K. F., Niwano, S., Takahashi, N., et al. (2023) · Circulation Journal · doi:10.1253/circj.cj-22-0827 · Cited by 76
Dynamic remodeling of intracellular Ca2+ signaling during atrial fibrillation
Greiser, M., & Schotten, U. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.12.020 · Cited by 72
Cost-effectiveness of Screening for Atrial Fibrillation Using Wearable Devices
Chen, W., Khurshid, S., Singer, D. E., Atlas, S. J., Ashburner, J. M., Ellinor, P. T., McManus, D. D., Lubitz, S. A., & Chhatwal, J. (2022) · JAMA Health Forum · doi:10.1001/jamahealthforum.2022.2419 · Cited by 61
Lord, J., Willis, S., Eatock, J., Tappenden, P., Trapero‐Bertran, M., Miners, A. H., Crossan, C., Westby, M. J., Anagnostou, A., Taylor, S. J. E., et al. (2013) · Health Technology Assessment · doi:10.3310/hta17580 · Cited by 70
Systematic screening for the detection of atrial fibrillation
Moran, P. S., Teljeur, C., Ryan, M., & Smith, S. M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009586.pub3 · Cited by 75
Effectiveness of systematic screening for the detection of atrial fibrillation
Moran, P. S., Flattery, M. J., Teljeur, C., Ryan, M., & Smith, S. M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009586.pub2 · Cited by 60
Chan, P.-H., Wong, C.-K., Pun, L., Wong, Y.-F., Wong, M. M.-Y., Chu, D. W.-S., & Siu, C.-W. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013685 · Cited by 58
Metadata
- Authors
- Hobbs, F., Fitzmaurice, D., Mant, J., Murray, E., Jowett, S., Bryan, S., Raftery, J., Davies, M., & Lip, G.
- Affiliations
- University of Birmingham (GB)
- Selly Oak Hospital (GB)
- Birmingham City Hospital (GB)
- Venue
- Health Technology Assessment
- Published
- 2005-10
- Volume
- 9
- Issue
- 40
- Pages
- iii-iv, ix
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W2018796325
- Semantic Scholar
- 6a762d2e553123cd54cf721ab5362f51c0e3da53
- Cited by
- 437
- References
- 60
- Citations by year
- 2026: 13 · 2025: 25 · 2024: 24 · 2023: 17 · 2022: 32 · 2021: 27 · 2020: 35 · 2019: 27 · 2018: 34 · 2017: 25 · 2016: 31 · 2015: 23 · 2014: 27 · 2013: 26 · 2012: 18
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Health Technology Assessment (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- ePrints Soton (University of Southampton) (submittedVersion)
- Apollo
- Funders
- Health Technology Assessment programme (96/22/11)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- atrial fibrillation, systematic screening, opportunistic screening, targeted screening, cost-effectiveness, ECG interpretation, irregular pulse, atrial fibrillation prevalence, atrial fibrillation incidence, older adults, primary care, atrial fibrillation risk factors, practice nurses, general practitioners, atrial fibrillation mortality
- MeSH terms
- Aged, Atrial Fibrillation, Cost-Benefit Analysis, Electrocardiography, Female, United Kingdom, Humans, Male, Mass Screening, Primary Health Care, Risk Factors, Incidence, Prevalence, Outcome Assessment, Health Care, Sample Size
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.